Global Syphilis Immunoassay Diagnostics Market Report and Forecast 2024-2032

Global Syphilis Immunoassay Diagnostics Market Report and Forecast 2024-2032


Global Syphilis Immunoassay Diagnostics Market Outlook

The global syphilis immunoassay diagnostics market size was valued at USD 0.41 billion in 2023, driven by the increasing prevalence of syphilis worldwide, necessitating efficient and accurate diagnostic solutions across the globe. The market size is anticipated to grow at a CAGR of 3.0% during the forecast period of 2024-2032 to achieve a value of USD 0.53 billion by 2032.

Syphilis Immunoassay Diagnostics: Introduction

Syphilis immunoassay diagnostics represent a vital tool in the medical field for the detection and diagnosis of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. These diagnostic tests employ immunoassay techniques, which utilize the body’s immune response to detect the presence of antibodies or antigens related to the syphilis bacterium. There are various types of immunoassays used, including enzyme immunoassays (EIAs), chemiluminescence immunoassays (CLIAs), and rapid immunochromatographic tests, each varying in sensitivity, specificity, and turnaround time. These tests are crucial for early detection and treatment of syphilis, helping to prevent serious health complications and the spread of the infection.

In addition to being used for individual diagnoses, syphilis immunoassays are also important in public health monitoring and screening programs. Their accuracy, ease of use, and rapid results make them an indispensable tool in combating this persistent and potentially severe infection.

Key Trends in the Global Syphilis Immunoassay Diagnostics Market

The global market for syphilis immunoassay diagnostics was witnessing several key trends. Firstly, there was a rising incidence of syphilis globally, partly due to increased awareness and screening, which was driving demand for diagnostic tests. Technological advancements were at the forefront, with a trend towards more rapid, sensitive, and specific immunoassays, enabling quicker and more accurate diagnoses. Automation in diagnostic laboratories was also a growing trend, leading to more efficient and high throughput testing capabilities. There was a notable increase in the adoption of point-of-care (POC) testing devices, which allowed for rapid syphilis screening in various settings, including clinics and community health centres.

Additionally, the integration of syphilis testing with other sexually transmitted infection (STI) tests in multiplex panels was becoming more common, offering a comprehensive screening approach. The market was also influenced by initiatives and funding from governments and global health organizations to combat the spread of STIs, including syphilis. Despite these positive trends, the market faced challenges such as the need for improved access to testing in low-resource settings and the requirement for continual education and training on the use of these diagnostic tools. Overall, these trends were shaping a dynamic and evolving market, reflecting the ongoing need to address syphilis as a public health concern.

Global Syphilis Immunoassay Diagnostics Market Segmentation

Market Breakup by Product Type
  • Analyzers
  • Kits
  • Reagents
Market Breakup by Technology
  • CLIA
  • ELISA
  • Others
Market Breakup by End User
  • Hospitals
  • Diagnostic Labs
  • Blood Banks
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Syphilis Immunoassay Diagnostics Market Overview

The global syphilis immunoassay diagnostics market was a significant and growing sector within the field of infectious disease diagnostics. This growth was primarily driven by the increasing prevalence of syphilis worldwide, necessitating efficient and accurate diagnostic solutions. North America and Europe were key regions in the market, characterized by advanced healthcare systems, high awareness about sexually transmitted infections (STIs), and well-established screening programs. However, there was also notable growth in regions like Asia Pacific and parts of Africa, driven by rising healthcare infrastructure, increased funding for STI control, and growing awareness about syphilis testing. The market comprised a range of immunoassay tests, including enzyme-linked immunoassays, rapid tests, and chemiluminescence assays, offered by both major healthcare companies and specialized diagnostics firms.

Technological advancements were leading to the development of more sensitive, specific, and user-friendly immunoassays. Despite these advancements, the market faced challenges such as disparities in access to diagnostic testing in low-resource settings and the need for continuous education about syphilis and its implications. Overall, the global syphilis immunoassay diagnostics market was poised for continued growth, underpinned by the essential need for accurate and accessible syphilis testing in global healthcare.

Global Syphilis Immunoassay Diagnostics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • BioRad Laboratories Inc
  • Danaher Corporation
  • BECTON DICKINSON & COMPANY
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Diasorin S.P.A
  • Abbott
  • Fujirebio
  • BioMerieux SA
  • Shenzhen New Industries Biomedical Engineering Co. Ltd
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Syphilis Disease Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Syphilis Disease Epidemiology Analysis – 7MM
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Syphilis Disease Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Syphilis Disease Epidemiology Forecast (2017-2032)
5.3.1 Germany Syphilis Disease Epidemiology Forecast (2017-2032)
5.3.2 France Syphilis Disease Epidemiology Forecast (2017-2032)
5.3.3 Italy Syphilis Disease Epidemiology Forecast (2017-2032)
5.3.4 Spain Syphilis Disease Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Syphilis Disease Epidemiology Forecast (2017-2032)
5.4 Japan Syphilis Disease Epidemiology Forecast (2017-2032)
6 Syphilis Immunoassay Diagnostic Market Overview – 7MM
6.1 Syphilis Immunoassay Diagnostic Market Historical Value (2017-2023)
6.2 Syphilis Immunoassay Diagnostic Market Forecast Value (2024-2032)
7 Syphilis Immunoassay Diagnostic Market Landscape – 7MM
7.1 Syphilis Immunoassay Diagnostic: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Syphilis Immunoassay Diagnostic Product Landscape
7.2.1 Analysis by Product Type
7.2.2 Analysis by Technology
8 Syphilis Immunoassay Diagnostic Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Syphilis Immunoassay Diagnostic Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Syphilis Immunoassay Diagnostic Market Segmentation – 7MM
11.1 Syphilis Immunoassay Diagnostic Market by Product Type
11.1.1 Market Overview
11.1.2 Analyzers
11.1.3 Kits
11.1.4 Reagents
11.2 Syphilis Immunoassay Diagnostic Market by Technology
11.2.1 Market Overview
11.2.2 CLIA
11.2.3 ELISA
11.2.4 Others
11.3 Syphilis Immunoassay Diagnostic Market by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Diagnostic Labs
11.3.4 Blood Banks
11.3.5 Others
11.4 Syphilis Immunoassay Diagnostic Market by Region
11.4.1 Market Overview
11.4.2 United States
11.4.3 EU-4 and the United Kingdom
11.4.3.1 Germany
11.4.3.2 France
11.4.3.3 Italy
11.4.3.4 Spain
11.4.3.5 United Kingdom
11.4.4 Japan
12 United States Syphilis Immunoassay Diagnostic Market
12.1 Syphilis Immunoassay Diagnostic Market Historical Value (2017-2023)
12.2 Syphilis Immunoassay Diagnostic Market Forecast Value (2024-2032)
12.3 Syphilis Immunoassay Diagnostic Market by Product Type
12.4 Syphilis Immunoassay Diagnostic Market by Technology
13 EU-4 and United Kingdom Syphilis Immunoassay Diagnostic Market
13.1 Syphilis Immunoassay Diagnostic Market Historical Value (2017-2023)
13.2 Syphilis Immunoassay Diagnostic Market Forecast Value (2024-2032)
13.3 Germany Syphilis Immunoassay Diagnostic Market Overview
13.3.1 Syphilis Immunoassay Diagnostic Market by Product Type
13.3.2 Syphilis Immunoassay Diagnostic Market by Technology
13.4 France Syphilis Immunoassay Diagnostic Market Overview
13.4.1 Syphilis Immunoassay Diagnostic Market by Product Type
13.4.2 Syphilis Immunoassay Diagnostic Market by Technology
13.5 Italy Syphilis Immunoassay Diagnostic Market Overview
13.5.1 Syphilis Immunoassay Diagnostic Market by Product Type
13.5.2 Syphilis Immunoassay Diagnostic Market by Technology
13.6 Spain Syphilis Immunoassay Diagnostic Market Overview
13.6.1 Syphilis Immunoassay Diagnostic Market by Product Type
13.6.2 Syphilis Immunoassay Diagnostic Market by Technology
13.7 United Kingdom Syphilis Immunoassay Diagnostic Market Overview
13.7.1 Syphilis Immunoassay Diagnostic Market by Product Type
13.7.2 Syphilis Immunoassay Diagnostic Market by Technology
14 Japan Syphilis Immunoassay Diagnostic Market
14.1 Syphilis Immunoassay Diagnostic Market Historical Value (2017-2023)
14.2 Syphilis Immunoassay Diagnostic Market Forecast Value (2024-2032)
14.3 Syphilis Immunoassay Diagnostic Market by Product Type
14.4 Syphilis Immunoassay Diagnostic Market by Technology
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 JAPAN PMDA
16 Patent Analysis
16.1 Analysis by Type of Patent
16.2 Analysis by Publication year
16.3 Analysis by Issuing Authority
16.4 Analysis by Patent Age
16.5 Analysis by CPC Analysis
16.6 Analysis by Patent Valuation
16.7 Analysis by Key Players
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding and Investment Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnerships and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 BioRad Laboratories Inc
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisitions
20.1.5 Certifications
20.2 Danaher Corporation
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisitions
20.2.5 Certifications
20.3 BECTON DICKINSON & COMPANY
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisitions
20.3.5 Certifications
20.4 F. Hoffmann-La Roche AG
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisitions
20.4.5 Certifications
20.5 Siemens Healthineers AG
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisitions
20.5.5 Certifications
20.6 Diasorin S.P.A
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisitions
20.6.5 Certifications
20.7 Abbott
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisitions
20.7.5 Certifications
20.8 Fujirebio
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisitions
20.8.5 Certifications
20.9 BioMerieux SA
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisitions
20.9.5 Certifications
20.10 Shenzhen New Industries Biomedical Engineering Co. Ltd
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisitions
20.10.5 Certifications
21 Syphilis Immunoassay Diagnostic Market- Distribution Model (Additional Insight)
21.1 Overview
21.2 Potential Distributors
21.3 Key Parameters for Distribution Partner Assessment
22 Key Opinion Leaders (KOL) Insights (Additional Insight)
23 Company Competitiveness Analysis (Additional Insight)
23.1 Very Small Companies
23.2 Small Companies
23.3 Mid-Sized Companies
23.4 Large Companies
23.5 Very Large Companies
24 Payment Methods (Additional Insight)
24.1 Government Funded
24.2 Private Insurance
24.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings